1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Slovakia Pharmaceuticals and Healthcare Report Q3 2016

Slovakia Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 91 pages

Includes 3 FREE quarterly updates

BMI View: Slovakia will remain a modest investment opportunity for multinational drugmakers. Whileexpenditure for both healthcare and pharmaceuticals is high, greater funding efficiency is needed. Recentyears have been turbulent for the healthcare sector, with a lack of progress on new legislation apparent.The appointment of a new minister of health is hoped to improve the situation, but the outlook remainsunclear.

Headline Expenditure Projections

- Pharmaceuticals: EUR1.91bn (USD2.10bn) in 2015 to EUR1.97bn (USD2.12bn) in 2016; +2.8% inlocal currency terms and +0.6% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: EUR6.15bn (USD6.76bn) in 2015 to EUR6.38bn (USD6.86bn) in 2016; +3.7% in localcurrency terms and +1.5% in US dollar terms. Forecast revised slightly downwards from last quarter.

Table Of Contents

Slovakia Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Slovakia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovakia 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020) 22
Generic Drug Market Forecast 23
Table: Members Of GENAS, 2015 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Slovakia 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovakia 2014-2020) 32
Industry Risk/Reward Index 33
Central And Eastern Europe Risk/Reward Index - Q3 2016 33
Slovakia Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Regulatory Regime 41
Intellectual Property Issues 44
Pricing Regime 45
Table: Indexed Price Build-Up For Prescription And Non-Prescription Medicines In Slovakia 46
Reimbursement Regime 46
Market Overview 52
Healthcare Sector 52
Table: Healthcare Resources (Slovakia 2010-2015) 55
Table: Healthcare Personnel (Slovakia 2010-2015) 55
Table: Healthcare Activity (Slovakia 2010-2015) 56
Research And Development 60
Table: Members Of BITCET, 2011 61
Table: Members Of SLOVBIOTECH, 2010 62
Clinical Trials 62
Epidemiology 63
Table: Main Causes Of Mortality And Morbidity In Slovakia 64
Competitive Landscape 66
Research-Based Industry 66
Table: Members Of SAFS, 2012 66
Table: Multinational Market Activity 67
Generic Drugmakers 68
Table: Registered Pharmaceutical Manufacturers 68
Pharmaceutical Distribution 69
Table: ADL Members, 2012 (Manufacturers, unless otherwise indicated) 70
Pharmaceutical Retail Sector 70
Company Profile 73
Biotika 73
HBM Pharma 75
Imuna Pharma 78
Demographic Forecast 80
Table: Population Headline Indicators (Slovakia 1990-2025) 81
Table: Key Population Ratios (Slovakia 1990-2025) 81
Table: Urban/Rural Population and Life Expectancy (Slovakia 1990-2025) 82
Table: Population By Age Group (Slovakia 1990-2025) 82
Table: Population By Age Group % (Slovakia 1990-2025) 83
Glossary 85
Methodology 87
Pharmaceutical Expenditure Forecast Model 87
Healthcare Expenditure Forecast Model 87
Notes On Methodology 88
Risk/Reward Index Methodology 89
Index Overview 90
Table: Pharmaceutical Risk/Reward Index Indicators 90
Indicator Weightings 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 750
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including domestic market, ...

Empty Capsules Market by Product, Non-Gelatin, Application & End User - Global Forecast to 2021

Empty Capsules Market by Product, Non-Gelatin, Application & End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • May 2016
  • by MarketsandMarkets

The global empty capsules market is estimated to reach USD 2.13 billion by 2021, growing at a CAGR of 7.2% during the forecast period (2016–2021). The factors driving this market are rapidly increasing ...

Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020

Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020

  • $ 5 650
  • Industry report
  • April 2016
  • by MarketsandMarkets

The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.